This inventor holds 1 USPTO granted patent. Top assignee: Ostuka Pharmaceutical Co., Ltd.. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Joseph E DeLarco: Innovator in Biopharmaceutical Purification
Introduction
Joseph E DeLarco is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of transforming growth factor-beta (TGF-beta). His innovative methods have the potential to enhance the efficiency of biopharmaceutical production.
Latest Patents
Joseph E DeLarco holds a patent for a "Method of purification of transforming growth factor-beta." This invention relates to improved methods for purifying TGF-beta to obtain high yields. The process involves several steps, including acid-ethanol extracting platelets, cation exchange separation, and hydrophobic separation. This patent showcases his expertise in biochemistry and his commitment to advancing medical science.
Career Highlights
DeLarco is currently associated with Otsuka Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His role at Otsuka allows him to collaborate with other experts and contribute to the development of new therapeutic methods.
Collaborations
One of his notable coworkers is James L Cone. Their collaboration highlights the importance of teamwork in the pursuit of scientific advancements.
Conclusion
Joseph E DeLarco's work in the purification of TGF-beta exemplifies the impact of innovation in the biopharmaceutical sector. His contributions are paving the way for more effective treatments and therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile